$AFCG
Advanced Flower Capital Inc. Stock $afcg

$afcg Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000182252324000045 Filed on November 13, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2023 Q3
Revenue		$8.882M	$15.27M
YoY Change		-41.84%	-15.81%
Cost Of Revenue		$981.8K	$3.570M
YoY Change		-72.5%	-6.66%
Gross Profit		$7.901M	$10.48M
YoY Change		-24.61%	-26.8%
Gross Profit Margin		88.95%	68.62%
Selling, General & Admin		$1.493M	$1.580M
YoY Change		-5.48%	6.05%
% of Gross Profit		18.9%	15.08%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses		$2.475M	$5.151M
YoY Change		-51.95%	-3.07%
Operating Profit		$5.425M	$5.329M
YoY Change		1.81%	-40.8%
Interest Expense		$1.573M	$1.533M
YoY Change		2.59%	-6.76%
% of Operating Profit		28.99%	28.77%
Other Income/Expense, Net		-$181.4K	-$1.050M
YoY Change		-82.73%	93.74%
Pretax Income		$1.604M	$8.643M
YoY Change		-81.44%	-25.8%
Income Tax		$386.3K	$700.0K
% Of Pretax Income		24.08%	8.1%
Net Earnings		$1.384M	$7.980M
YoY Change		-82.66%	-30.49%
Net Earnings / Revenue		15.58%	52.25%
Basic Earnings Per Share		$0.06	$0.39
Diluted Earnings Per Share		$0.06	$0.39
COMMON SHARES
Basic Shares Outstanding	21.95M shares	20.67M shares	20.46M shares
Diluted Shares Outstanding		20.79M shares	20.34M shares

Balance Sheet

Concept	2024 Q3	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$122.2M	$73.20M
YoY Change	66.89%	101.54%
Cash & Equivalents	$122.2M	$73.20M
Short-Term Investments
Other Short-Term Assets	$423.0K	$500.0K
YoY Change	-15.41%	-11.34%
Inventory
Prepaid Expenses
Receivables	$0.00
Other Receivables	$0.00
Total Short-Term Assets	$122.6M	$73.70M
YoY Change	66.33%	99.82%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00
YoY Change
Total Long-Term Assets	$244.0M	$371.4M
YoY Change	-34.29%	-14.51%
TOTAL ASSETS
Total Short-Term Assets	$122.6M	$73.70M
Total Long-Term Assets	$244.0M	$371.4M
Total Assets	$366.6M	$445.1M
YoY Change	-17.63%	-5.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$658.2K	$800.0K
YoY Change	-17.72%	-29.29%
Accrued Expenses	$4.031M	$7.600M
YoY Change	-46.97%	-44.52%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$71.93M	$18.20M
YoY Change	295.22%	-30.67%
LONG-TERM LIABILITIES
Long-Term Debt	$88.46M	$87.90M
YoY Change	0.64%	-9.35%
Other Long-Term Liabilities	$164.7K	$200.0K
YoY Change	-17.67%	-70.96%
Total Long-Term Liabilities	$88.63M	$88.10M
YoY Change	0.6%	-9.78%
TOTAL LIABILITIES
Total Short-Term Liabilities	$71.93M	$18.20M
Total Long-Term Liabilities	$88.63M	$88.10M
Total Liabilities	$160.6M	$106.3M
YoY Change	51.0%	-14.18%
SHAREHOLDERS EQUITY
Retained Earnings	-$42.35M	-$10.94M
YoY Change	287.03%	634.93%
Common Stock	$218.8K	$204.6K
YoY Change	6.96%	0.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$206.1M	$338.8M
YoY Change
Total Liabilities & Shareholders Equity	$366.6M	$445.1M
YoY Change	-17.63%	-5.56%

Cashflow Statement

Concept	2024 Q3	2023 Q3
OPERATING ACTIVITIES
Net Income	$1.384M	$7.980M
YoY Change	-82.66%	-30.49%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$2.644M	$5.460M
YoY Change	-51.58%	-55.36%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$6.990M	-$4.520M
YoY Change	54.65%	-76.7%
Cash From Investing Activities	-$6.990M	-$4.520M
YoY Change	54.65%	-76.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-43.79M	-9.820M
YoY Change	345.9%	368.54%
NET CHANGE
Cash From Operating Activities	2.644M	5.460M
Cash From Investing Activities	-6.990M	-4.520M
Cash From Financing Activities	-43.79M	-9.820M
Net Change In Cash	-48.13M	-8.880M
YoY Change	442.05%	-4.14%
FREE CASH FLOW
Cash From Operating Activities	$2.644M	$5.460M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	338772431	usd
	afcg	Proceeds From Principal Repayments Of Loans Held For Investment At Fair Value ProceedsFromPrincipalRepaymentsOfLoansHeldForInvestmentAtFairValue	4500000	usd
CY2023Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	61720705	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	17415218	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	17415218	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	29927714	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	340318237	usd
CY2023Q4	afcg	Contractual Obligation Drawn Loan Commitments ContractualObligationDrawnLoanCommitments	421239913	usd
CY2023Q4	us-gaap	Contractual Obligation ContractualObligation	10000000	usd
	us-gaap	Severance Costs1 SeveranceCosts1	700000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15265498	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	38018577	usd
CY2024Q3	afcg	Accrued Exchange Fee Rebate AccruedExchangeFeeRebate	180552	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001822523
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39995
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-1807125
	dei	Entity Address Address Line1 EntityAddressAddressLine1	477 S. Rosemary Ave.
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 301
	dei	Entity Address City Or Town EntityAddressCityOrTown	West Palm Beach
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	afcg	Severance Costs Period To Receive Base Salary SeveranceCostsPeriodToReceiveBaseSalary	P12M
CY2023Q1	afcg	Severance Cobra Premiums Paid Period SeveranceCOBRAPremiumsPaidPeriod	P12M
CY2023Q1	afcg	Share Based Compensation Arrangement By Share Based Payment Award Expiration Period Extension ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriodExtension	P1Y
	dei	Entity Registrant Name EntityRegistrantName	ADVANCED FLOWER CAPITAL INC.
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33401
	dei	City Area Code CityAreaCode	561
	dei	Local Phone Number LocalPhoneNumber	510-2390
	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value per share
	dei	Trading Symbol TradingSymbol	AFCG
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	21952677	shares
CY2024Q3	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	50950868	usd
CY2023Q4	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	71644003	usd
CY2024Q3	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	31372174	usd
CY2023Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	61720705	usd
CY2024Q3	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	234257042	usd
CY2023Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	301265398	usd
CY2024Q3	us-gaap	Notes Receivable Gross NotesReceivableGross	2040058	usd
CY2023Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	2040058	usd
CY2024Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	25111209	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	26309450	usd
CY2024Q3	us-gaap	Notes Receivable Net NotesReceivableNet	211185891	usd
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	276996006	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	122163732	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	90381831	usd
CY2024Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	0	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	1837450	usd
CY2024Q3	us-gaap	Interest Receivable InterestReceivable	1473644	usd
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	3715995	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	422967	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	688446	usd
CY2024Q3	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	0	usd
CY2023Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	31244622	usd
CY2024Q3	us-gaap	Assets Assets	366618408	usd
CY2023Q4	us-gaap	Assets Assets	466585055	usd
CY2024Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	2170417	usd
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	894000	usd
CY2024Q3	us-gaap	Other Liabilities OtherLiabilities	20587	usd
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	16437	usd
CY2024Q3	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	7221076	usd
CY2023Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	9819695	usd
CY2024Q3	us-gaap	Financing Receivable Covered Allowance For Credit Loss FinancingReceivableCoveredAllowanceForCreditLoss	164664	usd
CY2023Q4	us-gaap	Financing Receivable Covered Allowance For Credit Loss FinancingReceivableCoveredAllowanceForCreditLoss	115473	usd
CY2024Q3	us-gaap	Management Fee Payable ManagementFeePayable	981785	usd
CY2023Q4	us-gaap	Management Fee Payable ManagementFeePayable	3471726	usd
CY2024Q3	afcg	Accrued Direct Administrative Expenses AccruedDirectAdministrativeExpenses	878407	usd
CY2023Q4	afcg	Accrued Direct Administrative Expenses AccruedDirectAdministrativeExpenses	1486256	usd
CY2024Q3	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	658224	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	704685	usd
CY2024Q3	us-gaap	Senior Notes SeniorNotes	88461936	usd
CY2023Q4	us-gaap	Senior Notes SeniorNotes	88014558	usd
CY2024Q3	us-gaap	Line Of Credit LineOfCredit	60000000	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	42000000	usd
CY2024Q3	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	0	usd
CY2023Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	10000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	160557096	usd
CY2023Q4	us-gaap	Liabilities Liabilities	146532830	usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	125	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	125	shares
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21882047	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21882047	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20457697	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20457697	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	218821	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	204577	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	248194045	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	349805890	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-42351554	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-29958243	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	206061312	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	320052225	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	366618408	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	466585055	usd
CY2024Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	10455021	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	16798426	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	42767720	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	52974100	usd
CY2024Q3	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	1572705	usd
CY2023Q3	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	1532928	usd
	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	4749143	usd
	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	4776863	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8882316	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	48197237	usd
CY2023Q3	afcg	Accrued Exchange Fee Rebate AccruedExchangeFeeRebate	405276	usd
	afcg	Accrued Exchange Fee Rebate AccruedExchangeFeeRebate	769545	usd
	afcg	Accrued Exchange Fee Rebate AccruedExchangeFeeRebate	1311501	usd
CY2024Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	981785	usd
CY2023Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	3574867	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	8429575	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	10592579	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	857304	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	986772	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2941942	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4068780	usd
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	218643	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	294014	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1131208	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	705361	usd
CY2024Q3	us-gaap	Professional Fees ProfessionalFees	417466	usd
CY2023Q3	us-gaap	Professional Fees ProfessionalFees	295502	usd
	us-gaap	Professional Fees ProfessionalFees	1231906	usd
	us-gaap	Professional Fees ProfessionalFees	1135977	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	2475198	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	5151155	usd
	us-gaap	Operating Expenses OperatingExpenses	13734631	usd
	us-gaap	Operating Expenses OperatingExpenses	16502697	usd
CY2024Q3	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	181370	usd
CY2023Q3	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	1053398	usd
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-1149050	usd
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	149637	usd
CY2024Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	usd
CY2023Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-1213416	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-93338	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-1239800	usd
CY2024Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1986381	usd
CY2024Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-4621702	usd
CY2023Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	787799	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-9655396	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-1152810	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1604046	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	8635328	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	15684262	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	31138674	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	386256	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	663220	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	830591	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1005959	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	1217790	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	7972108	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	14853671	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	30132715	usd
CY2024Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	165944	usd
CY2023Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	7767	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	2922068	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	7767	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	1383734	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	7979875	usd
	us-gaap	Profit Loss ProfitLoss	17775739	usd
	us-gaap	Profit Loss ProfitLoss	30140482	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.05
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.39
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.71
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.47
CY2024Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.01
CY2023Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.14
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.39
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.85
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.47
CY2024Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.05
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.39
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.71
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.47
CY2024Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.01
CY2023Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.14
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.39
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.85
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.47
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20684149	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20324125	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20493375	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20315162	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20785848	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20342880	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20543644	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20390385	shares
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	314283821	usd
CY2024Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	12161367	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	218643	usd
CY2024Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.33
CY2024Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	7221076	usd
CY2024Q3	afcg	Additional Paid In Capital Distributions In Connection With Spin Off AdditionalPaidInCapitalDistributionsInConnectionWithSpinOff	114765177	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	1383734	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	206061312	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	294014	usd
CY2023Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.48
CY2023Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	9819695	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	7979875	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	320052225	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	12161367	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1131208	usd
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.44
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	30161550	usd
	us-gaap	Preferred Stock Dividends Per Share Cash Paid PreferredStockDividendsPerShareCashPaid	60
	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	7500	usd
	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	125000	usd
	afcg	Additional Paid In Capital Distributions In Connection With Spin Off AdditionalPaidInCapitalDistributionsInConnectionWithSpinOff	114765177	usd
	us-gaap	Profit Loss ProfitLoss	17775739	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	206061312	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	339059369	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	693441	usd
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.52
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	31113361	usd
	us-gaap	Preferred Stock Dividends Per Share Cash Paid PreferredStockDividendsPerShareCashPaid	60
	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	7500	usd
	us-gaap	Profit Loss ProfitLoss	30140482	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	338772431	usd
	us-gaap	Profit Loss ProfitLoss	17775739	usd
	us-gaap	Profit Loss ProfitLoss	30140482	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	2922068	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	7767	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	14853671	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	30132715	usd
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-1149050	usd
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	149637	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-93338	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-1239800	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1986381	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-9655396	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-1152810	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	7097310	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	4435186	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1131208	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	693441	usd
	afcg	Payment In Kind Interest PaymentInKindInterest	2798814	usd
	afcg	Payment In Kind Interest PaymentInKindInterest	9404473	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-2242351	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-673473	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-233257	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	79474	usd
	afcg	Increase Decrease In Interest Reserve IncreaseDecreaseInInterestReserve	0	usd
	afcg	Increase Decrease In Interest Reserve IncreaseDecreaseInInterestReserve	4149994	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1276417	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1130083	usd
	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	-2489941	usd
	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	-316867	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-607849	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-499024	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-42311	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-13504	usd
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	16064202	usd
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	14982587	usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	3271445	usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	7767	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	19335647	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	14990354	usd
	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	50022243	usd
	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	51757225	usd
	us-gaap	Proceeds From Sale Of Loans Held For Investment ProceedsFromSaleOfLoansHeldForInvestment	96061029	usd
	us-gaap	Proceeds From Sale Of Loans Held For Investment ProceedsFromSaleOfLoansHeldForInvestment	21312827	usd
	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	0	usd
	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	1000000	usd
	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	53259314	usd
	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	49953251	usd
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	99298100	usd
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	18508853	usd
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-47211339	usd
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	52086761	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	18508853	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	12335674	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	174307	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	240612	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	225000	usd
	us-gaap	Payments For Repurchase Of Redeemable Preferred Stock PaymentsForRepurchaseOfRedeemablePreferredStock	125000	usd
	us-gaap	Payments For Repurchase Of Redeemable Preferred Stock PaymentsForRepurchaseOfRedeemablePreferredStock	0	usd
	afcg	Payment Of Cash Distribution In Connection With Spin Off PaymentOfCashDistributionInConnectionWithSpinOff	67913215	usd
	afcg	Payment Of Cash Distribution In Connection With Spin Off PaymentOfCashDistributionInConnectionWithSpinOff	0	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	185000000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	21000000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	167000000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	81000000	usd
	us-gaap	Payments Of Ordinary Dividends PaymentsOfOrdinaryDividends	32767669	usd
	us-gaap	Payments Of Ordinary Dividends PaymentsOfOrdinaryDividends	32705006	usd
	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	0	usd
	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	7737500	usd
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-70885129	usd
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-100667506	usd
	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	0	usd
	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-70885129	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-100667506	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	537279	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-67168299	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	121626453	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	140372841	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	122163732	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	73204542	usd
	afcg	Interest Reserve Withheld From Funding Of Loan InterestReserveWithheldFromFundingOfLoan	0	usd
	afcg	Interest Reserve Withheld From Funding Of Loan InterestReserveWithheldFromFundingOfLoan	1500000	usd
	afcg	Original Issue Discount Withheld From Funding Of Loans OriginalIssueDiscountWithheldFromFundingOfLoans	5411310	usd
	afcg	Original Issue Discount Withheld From Funding Of Loans OriginalIssueDiscountWithheldFromFundingOfLoans	7398475	usd
CY2024Q3	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	7221076	usd
CY2023Q3	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	9819695	usd
	us-gaap	Notes Issued1 NotesIssued1	14672640	usd
	us-gaap	Notes Issued1 NotesIssued1	0	usd
	afcg	Non Cash Net Assets Distribution In Connection With Spin Off NonCashNetAssetsDistributionInConnectionWithSpinOff	46851962	usd
	afcg	Non Cash Net Assets Distribution In Connection With Spin Off NonCashNetAssetsDistributionInConnectionWithSpinOff	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	2708888	usd
	us-gaap	Interest Paid Net InterestPaidNet	2951250	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	939046	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1078959	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates in the Preparation of Financial Statements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant estimates include the valuation of loans held for investment at fair value and current expected credit losses (“CECL”).</span></div>
	afcg	Number Of Loans Held For Investments In Portfolio NumberOfLoansHeldForInvestmentsInPortfolio	1	loan
CY2023	afcg	Number Of Loans Held For Investments In Portfolio NumberOfLoansHeldForInvestmentsInPortfolio	2	loan
CY2024Q3	afcg	Loans Held For Investment At Fair Value Aggregate Commitments LoansHeldForInvestmentAtFairValueAggregateCommitments	85300000	usd
CY2023Q4	afcg	Loans Held For Investment At Fair Value Aggregate Commitments LoansHeldForInvestmentAtFairValueAggregateCommitments	94200000	usd
CY2024Q3	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	53800000	usd
CY2023Q4	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	71900000	usd
	afcg	Loans Held For Investment At Fair Value Funded Of Outstanding Principal LoansHeldForInvestmentAtFairValueFundedOfOutstandingPrincipal	4600000	usd
	afcg	Proceeds From Sale Of Loans Held For Investment At Fair Value ProceedsFromSaleOfLoansHeldForInvestmentAtFairValue	19300000	usd
CY2024Q3	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	31372174	usd
CY2024Q3	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	50950868	usd
CY2024Q3	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	53818300	usd
	afcg	Loans Held For Investment At Fair Value Weighted Average Remaining Life LoansHeldForInvestmentAtFairValueWeightedAverageRemainingLife	P0Y
CY2023Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	61720705	usd
CY2023Q4	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	71644003	usd
CY2023Q4	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	71883402	usd
CY2023	afcg	Loans Held For Investment At Fair Value Weighted Average Remaining Life LoansHeldForInvestmentAtFairValueWeightedAverageRemainingLife	P0Y4M24D
CY2023Q4	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	71883402	usd
CY2023Q4	afcg	Loans Held For Investment At Fair Value Original Issue Discount LoansHeldForInvestmentAtFairValueOriginalIssueDiscount	239399	usd
CY2023Q4	afcg	Loans Held For Investment At Fair Value Unrealized Gains Losses LoansHeldForInvestmentAtFairValueUnrealizedGainsLosses	-9923298	usd
	afcg	Loans Held For Investment At Fair Value Unrealized Gains Losses Change In Unrealized Gains Losses On Loans At Fair Value Net LoansHeldForInvestmentAtFairValueUnrealizedGainsLossesChangeInUnrealizedGainsLossesOnLoansAtFairValueNet	-9655396	usd
	afcg	Loans Held For Investment At Fair Value Change In Unrealized Gains Losses On Loans At Fair Value Net LoansHeldForInvestmentAtFairValueChangeInUnrealizedGainsLossesOnLoansAtFairValueNet	-9655396	usd
	afcg	Loans Held For Investment At Fair Value Outstanding Principal New Fundings LoansHeldForInvestmentAtFairValueOutstandingPrincipalNewFundings	4594027	usd
	afcg	Loans Held For Investment At Fair Value Original Issue Discount New Funding LoansHeldForInvestmentAtFairValueOriginalIssueDiscountNewFunding	2756417	usd
	afcg	Loans Held For Investment At Fair Value New Funding LoansHeldForInvestmentAtFairValueNewFunding	1837610	usd
	afcg	Loans Held For Investment At Fair Value Original Issue Discount Accretion Of Original Issue Discount LoansHeldForInvestmentAtFairValueOriginalIssueDiscountAccretionOfOriginalIssueDiscount	128384	usd
	afcg	Loans Held For Investment At Fair Value Accretion Of Original Issue Discount LoansHeldForInvestmentAtFairValueAccretionOfOriginalIssueDiscount	128384	usd
	afcg	Proceeds From Principal Repayments Of Loans Held For Investment At Fair Value Outstanding Principal ProceedsFromPrincipalRepaymentsOfLoansHeldForInvestmentAtFairValueOutstandingPrincipal	4509069	usd
	afcg	Proceeds From Principal Repayments Of Loans Held For Investment At Fair Value ProceedsFromPrincipalRepaymentsOfLoansHeldForInvestmentAtFairValue	4509069	usd
	afcg	Proceeds From Sale Of Loans Held For Investment At Fair Value Outstanding Principal ProceedsFromSaleOfLoansHeldForInvestmentAtFairValueOutstandingPrincipal	19284846	usd
	afcg	Proceeds From Sale Of Loans Held For Investment At Fair Value ProceedsFromSaleOfLoansHeldForInvestmentAtFairValue	19284846	usd
	afcg	Loans Held For Investment At Fair Value Outstanding Principal Payment In Kind Interest LoansHeldForInvestmentAtFairValueOutstandingPrincipalPaymentInKindInterest	1134786	usd
	afcg	Loans Held For Investment At Fair Value Payment In Kind Interest LoansHeldForInvestmentAtFairValuePaymentInKindInterest	1134786	usd
CY2024Q3	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	53818300	usd
CY2024Q3	afcg	Loans Held For Investment At Fair Value Original Issue Discount LoansHeldForInvestmentAtFairValueOriginalIssueDiscount	2867432	usd
CY2024Q3	afcg	Loans Held For Investment At Fair Value Unrealized Gains Losses LoansHeldForInvestmentAtFairValueUnrealizedGainsLosses	-19578694	usd
CY2024Q3	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	31372174	usd
CY2024Q3	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	31372174	usd
CY2024Q3	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	50950868	usd
CY2024Q3	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	53818300	usd
	afcg	Number Of Loans Held For Investments NumberOfLoansHeldForInvestments	11	loan
CY2023	afcg	Number Of Loans Held For Investments NumberOfLoansHeldForInvestments	9	loan
CY2024Q3	afcg	Loans Held For Investment At Carrying Value Aggregate Commitments LoansHeldForInvestmentAtCarryingValueAggregateCommitments	260200000	usd
CY2023Q4	afcg	Loans Held For Investment At Carrying Value Aggregate Commitments LoansHeldForInvestmentAtCarryingValueAggregateCommitments	333100000	usd
CY2024Q3	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	242800000	usd
CY2023Q4	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	314400000	usd
	afcg	Loans Held For Investment At Carrying Value Outstanding Principal New Fundings LoansHeldForInvestmentAtCarryingValueOutstandingPrincipalNewFundings	65500000	usd
	afcg	Receivable With Imputed Interest Loan Repayments And Amortization Payments ReceivableWithImputedInterestLoanRepaymentsAndAmortizationPayments	48800000	usd
	afcg	Receivable With Imputed Interest Sale Of Loans Face Amount ReceivableWithImputedInterestSaleOfLoansFaceAmount	90000000.0	usd
CY2024Q3	afcg	Percentage Of Loans Held With Floating Interest Rates PercentageOfLoansHeldWithFloatingInterestRates	0.47
CY2023Q4	afcg	Percentage Of Loans Held With Floating Interest Rates PercentageOfLoansHeldWithFloatingInterestRates	0.84
CY2024Q3	afcg	Loans Held For Investment Interest Rate Floor LoansHeldForInvestmentInterestRateFloor	0.036
CY2024Q3	afcg	Loans Held For Investment Quoted Interest Rate LoansHeldForInvestmentQuotedInterestRate	0.048
CY2024Q3	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	242802878	usd
CY2024Q3	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	8545836	usd
CY2024Q3	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	234257042	usd
	afcg	Loans Held For Investment Weighted Average Remaining Life LoansHeldForInvestmentWeightedAverageRemainingLife	P2Y
CY2023Q4	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	314376929	usd
CY2023Q4	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	13111531	usd
CY2023Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	301265398	usd
CY2023	afcg	Loans Held For Investment Weighted Average Remaining Life LoansHeldForInvestmentWeightedAverageRemainingLife	P2Y2M12D
CY2023Q4	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	314376929	usd
CY2023Q4	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	13111531	usd
CY2023Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	301265398	usd
	afcg	Receivable With Imputed Interest New Funding Face Amount ReceivableWithImputedInterestNewFundingFaceAmount	65512166	usd
	afcg	Receivable With Imputed Interest Discount On New Funding ReceivableWithImputedInterestDiscountOnNewFunding	2654893	usd
	afcg	Receivable With Imputed Interest New Funding Net Amount ReceivableWithImputedInterestNewFundingNetAmount	62857273	usd
	afcg	Receivable With Accretion Of Original Issue Discount Premium ReceivableWithAccretionOfOriginalIssueDiscountPremium	6968926	usd
	afcg	Accretion Of Original Issue Discount Net Amount AccretionOfOriginalIssueDiscountNetAmount	6968926	usd
	afcg	Receivable With Imputed Interest Loan Repayments Face Amount ReceivableWithImputedInterestLoanRepaymentsFaceAmount	45237624	usd
	afcg	Receivable With Imputed Interest Loan Repayments ReceivableWithImputedInterestLoanRepayments	45237624	usd
	afcg	Receivable With Imputed Interest Sale Of Loans Face Amount ReceivableWithImputedInterestSaleOfLoansFaceAmount	90000000	usd
	afcg	Receivable With Imputed Interest Sale Of Loans Original Issue Discount ReceivableWithImputedInterestSaleOfLoansOriginalIssueDiscount	251662	usd
	afcg	Receivable With Sale Of Loans Net Amount ReceivableWithSaleOfLoansNetAmount	89748338	usd
	afcg	Receivable With Paid In Kind Interest Face Amount ReceivableWithPaidInKindInterestFaceAmount	1664028	usd
	afcg	Receivable With Paid In Kind Interest Net Amount ReceivableWithPaidInKindInterestNetAmount	1664028	usd
	afcg	Receivable With Imputed Interest Amortization Payments ReceivableWithImputedInterestAmortizationPayments	3512621	usd
	afcg	Receivable With Imputed Interest Loan Amortization Payments ReceivableWithImputedInterestLoanAmortizationPayments	3512621	usd
CY2024Q3	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	242802878	usd
CY2024Q3	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	8545836	usd
CY2024Q3	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	234257042	usd
CY2024Q3	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	242802878	usd
CY2024Q3	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	8545836	usd
CY2024Q3	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	234257042	usd
CY2024Q3	afcg	Number Of Portfolio Loans NumberOfPortfolioLoans	1	loan
CY2023Q4	afcg	Number Of Portfolio Loans NumberOfPortfolioLoans	1	loan
CY2024Q3	afcg	Loans Receivable At Carrying Value Aggregate Commitments LoansReceivableAtCarryingValueAggregateCommitments	4000000.0	usd
CY2023Q4	afcg	Loans Receivable At Carrying Value Aggregate Commitments LoansReceivableAtCarryingValueAggregateCommitments	4000000.0	usd
CY2023Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	2000000.0	usd
CY2024Q3	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	2000000.0	usd
CY2023Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	2041744	usd
CY2023Q4	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	1686	usd
CY2023Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	2040058	usd
	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	0	usd
	afcg	Payments On Loans Receivable Carrying Value PaymentsOnLoansReceivableCarryingValue	0	usd
CY2024Q3	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	2041744	usd
CY2024Q3	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	1686	usd
CY2024Q3	us-gaap	Notes Receivable Gross NotesReceivableGross	2040058	usd
CY2024Q3	us-gaap	Financing Receivable Originated In Current Fiscal Year FinancingReceivableOriginatedInCurrentFiscalYear	56832385	usd
CY2024Q3	us-gaap	Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear	27573208	usd
CY2024Q3	us-gaap	Financing Receivable Originated Two Years Before Latest Fiscal Year FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear	49002019	usd
CY2024Q3	us-gaap	Financing Receivable Originated Three Years Before Latest Fiscal Year FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear	100849430	usd
CY2024Q3	us-gaap	Financing Receivable Originated Four Years Before Latest Fiscal Year FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear	2040058	usd
CY2024Q3	afcg	Loans Held For Investment And Financing Receivable Before Allowance For Credit Loss LoansHeldForInvestmentAndFinancingReceivableBeforeAllowanceForCreditLoss	236297100	usd
CY2024Q3	afcg	Interest Receivables InterestReceivables	1397114	usd
CY2023Q4	afcg	Interest Receivables InterestReceivables	2680188	usd
CY2024Q3	afcg	Payment In Kind Receivable PaymentInKindReceivable	38764	usd
CY2023Q4	afcg	Payment In Kind Receivable PaymentInKindReceivable	1009974	usd
CY2024Q3	afcg	Unused Fees Receivable UnusedFeesReceivable	37766	usd
CY2023Q4	afcg	Unused Fees Receivable UnusedFeesReceivable	25833	usd
CY2024Q3	us-gaap	Interest Receivable InterestReceivable	1473644	usd
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	3715995	usd
CY2023	afcg	Number Of Loans Included In Loan Funded Interest Reserve NumberOfLoansIncludedInLoanFundedInterestReserve	0	loan
	afcg	Number Of Loans Included In Loan Funded Interest Reserve NumberOfLoansIncludedInLoanFundedInterestReserve	0	loan
CY2024Q3	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	0	usd
	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	0	usd
CY2023Q3	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	600000	usd
	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	4200000	usd
CY2024Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	0	usd
CY2023Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	1130541	usd
CY2023Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	0	usd
CY2022Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3200944	usd
CY2024Q3	afcg	New Reserves Interest NewReservesInterest	0	usd
CY2023Q3	afcg	New Reserves Interest NewReservesInterest	0	usd
	afcg	New Reserves Interest NewReservesInterest	0	usd
	afcg	New Reserves Interest NewReservesInterest	1526065	usd
CY2024Q3	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	0	usd
CY2023Q3	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	579591	usd
	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	0	usd
	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	4176059	usd
CY2024Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	0	usd
CY2023Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	550950	usd
CY2024Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	0	usd
CY2023Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	550950	usd
CY2022Q2	afcg	Line Of Credit Facility Accordion Feature Increase Limit LineOfCreditFacilityAccordionFeatureIncreaseLimit	100000000.0	usd
CY2024Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	1315417	usd
CY2024Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	257288	usd
CY2024Q3	us-gaap	Interest Expense InterestExpense	1572705	usd
CY2023Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	1304250	usd
CY2023Q3	afcg	Line Of Credit Facility Unused Fee Expense LineOfCreditFacilityUnusedFeeExpense	26667	usd
CY2023Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	255345	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	1532928	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	3985304	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	763839	usd
	us-gaap	Interest Expense InterestExpense	4749143	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	4033417	usd
	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	47915	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	695531	usd
	us-gaap	Interest Expense InterestExpense	4776863	usd
CY2024Q3	afcg	Contractual Obligation Loan Commitments ContractualObligationLoanCommitments	349532028	usd
CY2023Q4	afcg	Contractual Obligation Loan Commitments ContractualObligationLoanCommitments	431239913	usd
CY2024Q3	afcg	Contractual Obligation Drawn Loan Commitments ContractualObligationDrawnLoanCommitments	329390255	usd
CY2024Q3	us-gaap	Contractual Obligation ContractualObligation	20141773	usd
CY2023Q1	afcg	Severance Cobra Premiums Paid Percentage SeveranceCOBRAPremiumsPaidPercentage	1
CY2023Q1	afcg	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Vesting Number Of Tranches ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingNumberOfTranches	1	tranche
	us-gaap	Severance Costs1 SeveranceCosts1	0	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	0	shares
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	0	shares
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	218643	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	294014	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1131208	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	705361	usd
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	156367	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	206304	shares
CY2024Q3	afcg	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Cumulative Number Of Shares ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedCumulativeNumberOfShares	2218265	shares
CY2023Q4	afcg	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Cumulative Number Of Shares ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedCumulativeNumberOfShares	2168328	shares
CY2024Q3	afcg	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises Cumulative ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesCumulative	5511	shares
CY2023Q4	afcg	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises Cumulative ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesCumulative	5511	shares
CY2024Q3	afcg	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Cumulative Number Of Shares ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedCumulativeNumberOfShares	200169	shares
CY2023Q4	afcg	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Cumulative Number Of Shares ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedCumulativeNumberOfShares	200169	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2168952	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2168952	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2168952	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.46
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2168952	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.46
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y6M7D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	529236	usd
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2129108	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	11.44
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y6M3D
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	526559	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2024Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	22200	usd
CY2024Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1600000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	1217790	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	7972108	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	14853671	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	30132715	usd
CY2024Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	usd
CY2023Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	7500	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	7500	usd
CY2024Q3	us-gaap	Dividends Dividends	167625	usd
CY2023Q3	us-gaap	Dividends Dividends	65991	usd
	us-gaap	Dividends Dividends	353021	usd
	us-gaap	Dividends Dividends	205268	usd
CY2024Q3	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	1050165	usd
CY2024Q3	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	1050165	usd
CY2023Q3	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	7906117	usd
CY2023Q3	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	7906117	usd
	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	14493150	usd
	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	14493150	usd
	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	29919947	usd
	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	29919947	usd
CY2024Q3	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted	165944	usd
CY2024Q3	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	165944	usd
CY2023Q3	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted	7767	usd
CY2023Q3	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	7767	usd
	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted	2922068	usd
	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	2922068	usd
	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted	7767	usd
	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	7767	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1216109	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1216109	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	7913884	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7913884	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	29927714	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20684149	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20324125	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20493375	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20315162	shares
CY2024Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	101699	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	18755	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	50269	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	75223	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20785848	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20342880	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20543644	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20390385	shares
CY2024Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.05
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.39
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.71
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.47
CY2024Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.01
CY2023Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.14
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.39
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.85
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.47
CY2024Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.05
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.39
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.71
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.47
CY2024Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.01
CY2023Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.14
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.39
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.85
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.47
CY2024Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1499235	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1499235	shares
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2288419	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2247328	shares
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	400000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	800000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	700000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000000.0	usd
CY2024Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	394210	usd
CY2023Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	663220	usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	838545	usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1005689	usd
CY2024Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2024Q3	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	-7954	usd
CY2023Q3	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	0	usd
	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	-7954	usd
	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	270	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	386256	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	663220	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	830591	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1005959	usd
CY2024Q3	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	300000	usd
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	600000	usd
CY2024Q3	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	100000	usd
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	200000	usd
CY2023Q3	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	500000	usd
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	700000	usd
CY2023Q3	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	200000	usd
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	300000	usd
CY2024Q3	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	-8000.0	usd
	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	-8000.0	usd
CY2023Q3	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	0	usd
	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	0	usd
	afcg	Exercise Tax As A Percentage Of Undistributed Ordinary Income And Net Capital Gains ExerciseTaxAsAPercentageOfUndistributedOrdinaryIncomeAndNetCapitalGains	0.04
CY2024Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2024Q3	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	31372174	usd
CY2024Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	31372174	usd
CY2023Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	61720705	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	61720705	usd
CY2024Q3	afcg	Incentive Compensation IncentiveCompensation	300000	usd
	afcg	Incentive Compensation IncentiveCompensation	5600000	usd
CY2023Q3	afcg	Incentive Compensation IncentiveCompensation	2600000	usd
	afcg	Incentive Compensation IncentiveCompensation	7900000	usd
CY2024Q3	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	1584711	usd
CY2023Q3	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	4392852	usd
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	10564764	usd
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	13393793	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.52
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	31113361	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.44
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	30161550	usd

Files In Submission

Name	View Source	Status
0001822523-24-000045-index-headers.html	Edgar Link	pending
0001822523-24-000045-index.html	Edgar Link	pending
0001822523-24-000045.txt	Edgar Link	pending
0001822523-24-000045-xbrl.zip	Edgar Link	pending
afcg-20240930.htm	Edgar Link	pending
afcg-20240930.xsd	Edgar Link	pending
afcg-20240930xex311.htm	Edgar Link	pending
afcg-20240930xex312.htm	Edgar Link	pending
afcg-20240930xex321.htm	Edgar Link	pending
afcg-20240930xex322.htm	Edgar Link	pending
afcg-20240930_g1.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
afcg-20240930_def.xml	Edgar Link	unprocessable
afcg-20240930_lab.xml	Edgar Link	unprocessable
afcg-20240930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
afcg-20240930_htm.xml	Edgar Link	completed
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
afcg-20240930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AFCG
Advanced Flower Capital Inc. Stock $afcg

2024 Q4 Form 10-Q Financial Statement

#000182252324000045 Filed on November 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AFCG Advanced Flower Capital Inc. Stock $afcg

2024 Q4 Form 10-Q Financial Statement

#000182252324000045 Filed on November 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AFCG
Advanced Flower Capital Inc. Stock $afcg